FDA
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
-
-
-
-
-
-
-
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
-
-
-
-
-
-
-
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
-
-
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


